"UCB is proud to support the work that the Vivli team is undertaking to drive collaboration and data sharing, as we believe this will enhance disease understanding, generate new insights, and may help develop new treatments to benefit patients worldwide."
Professor Dr. Iris Loew-Friedrich, chief medical officer and executive vice president, UCB